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Abstract
Background: Quantification of phospho-proteins (PPs) is crucial when studying cellular signaling pathways. Western
immunoblotting (WB) is commonly used for the measurement of relative levels of signaling intermediates in experimental
samples. However, WB is in general a labour-intensive and low-throughput technique. Because of variability in protein yield
and phospho-signal preservation during protein harvesting, and potential loss of antigen during protein transfer, WB
provides only semi-quantitative data. By comparison, the ‘‘in-cell western’’ (ICW) technique has high-throughput capacity
and requires less extensive sample preparation. Thus, we compared the ICW technique to WB for measuring phosphorylated
myosin regulatory light chain (PMLC20) in primary cultures of uterine myocytes to assess their relative specificity, sensitivity,
precision, and quantification of biologically relevant responses.
Methodology/Principal Findings: ICWs are cell-based microplate assays for quantification of protein targets in their cellular
context. ICWs utilize a two-channel infrared (IR) scanner (OdysseyH) to quantify signals arising from near-infrared (NIR)
fluorophores conjugated to secondary antibodies. One channel is dedicated to measuring the protein of interest and the
second is used for data normalization of the signal in each well of the microplate. Using uterine myocytes, we assessed
oxytocin (OT)-stimulated MLC20 phosphorylation measured by ICW and WB, both using NIR fluorescence. ICW and WB data
were comparable regarding signal linearity, signal specificity, and time course of phosphorylation response to OT.
Conclusion/Significance: ICW and WB yield comparable biological data. The advantages of ICW over WB are its high-
throughput capacity, improved precision, and reduced sample preparation requirements. ICW might provide better
sensitivity and precision with low-quantity samples or for protocols requiring large numbers of samples. These features
make the ICW technique an excellent tool for the study of phosphorylation endpoints. However, the drawbacks of ICW
include the need for a cell culture format and the lack of utility where protein purification, concentration or stoichiometric
analyses are required.
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Introduction
Western immunoblotting (WB) is widely utilized to study
relative levels of signaling intermediates including a variety of
phospho-proteins (PPs). The increasing availability of antibodies
for specific PPs has enhanced the popularity of this relatively
inexpensive technique. Recently, there has been increasing use of
near-infrared (NIR) fluorophore–conjugated antibodies for the
WB technique. Compared to chemiluminescent antigen detection,
NIR fluorophores extended the linear range of detection and
potentially improve WB sensitivity. [1,2] These two properties
improve quantification of highly abundant or relatively scarce
proteins in cell lysates. Currently available NIR scanners
(OdysseyH) for this purpose have two separate channels. This
enables simultaneous detection of two different proteins, providing
that the primary antibodies are raised in different species and that
the species-specific secondary antibodies are labeled with different
fluorophores. This segregation of signals is particularly useful in
phosphorylation studies since it facilitates normalization of the PP
signal to that of the total protein. However, WB continues to be a
low-throughput, labour intensive technique. An additional con-
sideration for the assessment of PPs is the potential for excessive
variability particularly during protein transfer from the gel to the
membrane, which might diminish the precision of the assay. [3,4]
The in-cell-western (ICW) technique is a cell-based assay for the
measurement of proteins in their cellular context. ICWs utilize 96-
well or 384-well microplates into which adherent or non-adherent
cells can be plated and analyzed using the OdysseyH scanner. This
methodology requires the segregation of signals derived from the
protein of interest (POI) and a normalization signal (reference protein
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or total cell content) into one of the two detection channels. ICWs
eliminate the need for protein harvesting, lysate preparation,
electrophoretic separation and electrophoretic transfer steps.
However, due to the absence of a protein separation step, ICWs
require that primary antibodies be highly specific for the POIs in
the context of microscopy. Currently, only a few reports contain
data produced by ICWs, and none of these include thorough
validations of the ICW technique beyond evaluating antibody
specificity using WB. [5,6,7,8,9] In this work, we attempted a more
thorough technical evaluation of ICWs using NIR fluorescence-
based WBs as a reference standard, thus eliminating the signal
detection methodology as a confounding factor in comparing the
two techniques. Further, we evaluated the ability of both
techniques to measure a phosphorylation event in response to a
physiological stimulus. Our endpoint of choice was the phosphor-
ylation of myosin regulatory light chain (MLC20) in cultured
human uterine myocytes. Phosphorylation of MLC20 at Ser
19 in
smooth muscle cells is a well characterized event that permits the
myosin(II)-actin cross-bridging and is the hallmark biochemical
event leading to tissue-level force production. We therefore
monitored phospho(Ser
19)-MLC20 (PMLC20) formation in cultured
uterine myocytes stimulated with oxytocin (OT), the most potent
biological stimulant for this cell type.
This work addressed two specific aims: 1) to assess and compare
the linearity, specificity and precision of signals measurable by WB
and ICW, and 2) to evaluate the ability of ICWs to yield
comparable data to WB regarding concentration- and time-
dependency of physiological phosphorylation events. Our broader
goal was to determine the suitability of ICW as a technique that
may be substituted for WB in signaling studies, particularly for
high-throughput experimental protocols.
Results
Signal Linearity and Specificity for WB and ICW
We assessed the linearity of both phosphorylated (PMLC20) and
non-phosphorylated (GAPDH, total MLC20) signals via WBs
prepared using 2-fold serial dilutions of uterine myocyte lysates
starting at 50 mg total protein/lane. Preliminary experiments
measuring GAPDH reached a lower limit of 0.19 mg protein/lane
and showed that WB could not discriminate between protein loads
#1.6 mg/lane. Therefore 1.6 mg/lane was selected as the lowest
load for subsequent experiments. Of four replicate membranes
prepared simultaneously to measure GAPDH, three of these
revealed a good ability to discriminate antigen signal intensities.
However, the signals from the fourth membrane could not
discriminate bands in lanes loaded with less than 12.5 mg protein/
well. The data from representative membranes for signals from
GAPDH, PMLC20 and total MLC20 ranging from 50 to 1.6 mg/
lane are shown in Figure 1. Though all three proteins may be
quantified above 50 mg protein/lane (lane 1) in our experience,
loading Tris-Glycine minigels with greater protein loads may
decrease band resolution. The high correlation coefficients over this
range for GAPDH, total MLC20, and PMLC20 (0.97, 0.99, 0.97,
respectively: Figure 1B) support the conclusion that this technique
can detect changes in specific protein concentrations. Even when
the analysis is restricted to protein applications less than #12.5 mg/
lane (Figure 1B inset), the correlation coefficients remain high for
GAPDH (0.87) total MLC20 (0.98) and PMLC20 (0.96).
The specificity of the antibodies was assessed in Figure 2. The full
length WB demonstrates the expected prominent bands relative to
the molecular weight (MW) marker for each of the proteins
(Figure 2A). Thoughbandsofdifferentsizes aredetectableatseveral
other positions, their relative intensities compared to the predom-
inant bands are considered quantitatively insignificant (,5% signal
relative to the band of interest). Probing with anti-GAPDH and
anti-PMLC20 antibodies simultaneously (as performed for subse-
quent concentration- and time-response experiments) revealed two
clear and prominent bands at the correct MWs (not shown).
Introduction of 30 mM phos-tag into the polyacrylamide matrix
markedly enhances separation of phosphorylated proteins by
retarding their movement. [10] Our data (Figure 2B) demonstrate
that the anti-PMLC20 antibody recognizes only the phosphorylated
(mono- and di-) MLC20 species, in contrast to the anti-total MLC20
antibody, which reveals the unphosphorylated form as well as the
mono- and diphospho-MLC20 (PPMLC20). For reference, the anti-
PPMLC20 antibody identifies only the uppermost band in these last
three panels, which corresponds to PPMLC20. These results
confirm those in a previous study and indicate the highly specific
nature of these antibodies. [11]
Figure 1. Signal linearity with western blots. A. Tris-Glycine-SDS
gels were loaded with total uterine myocyte lysate (2-fold dilutions
from 50 mg to 1.6 mg). GAPDH, total MLC20, and phospho(Ser19)-
MLC20 (PMLC20) were detectable with 1.6 mg total protein/lane. B.
Quantification of bands shown in panel A. Normalized values are
expressed as a fraction of the band intensity measured at 50 mg/lane.
Fit of a linear model through the origin showed excellent correlation for
all three proteins (GAPDH:N; MLC20: &; PMLC20: m). The inset graph
illustrates the correlation coefficient when only the lanes with #12.5 mg
protein are analyzed. Molecular weight markers (MW) are shown at the
left.
doi:10.1371/journal.pone.0009965.g001
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number for ICWs using the antibody to PMLC20, and two
normalization references (Figure 3). The first normalization
reference used an antibody toward GAPDH. The second utilized
a combination of two cell dyes (DRAQ5 [12] and Sapphire700,
referred to as ‘‘cell dyes’’ in this manuscript) that provide an
estimate of the cell content of the well and is detected in a separate
channel of the IR scanner. Uterine myocytes were seeded into 96-
well plates (15 mm
2/well) from 750 cells/well through to
15,000 cells/well, resulting in adherent monolayers corresponding
to cell densities of 0, 50, 100, 200, 300, 400, 500, 600, 700, 800,
900, and 1000 cells/mm
2 (Figure 3A). Signals were detectable
above background readings (empty wells) down to 750 cells/well.
It was apparent that the relationship between cell numbers and
concentrations of PMLC20 and GAPDH (Figure 3B) was
plateauing at cell numbers beyond 10,500/well (700 cells/mm
2).
Using only the cells with equal to or less than cell density
700 cells/mm
2 (inset), the correlation coefficients to a linear model
for both GAPDH (0.99) and PMLC20 (0.96) were very high,
supporting the conclusion that this assay has precision to measure
changes in protein concentrations with optimal performance using
1,000–10,500 cells/well, which corresponds to 0.3 to 4 mg
protein/well, based on average lysate yields for this cell type.
Further, these data suggest that ICWs exhibit improved sensitivity
compared to WB as we reliably measured GAPDH in ICWs below
the lower limit of signal discrimination (1.6 mg/lane) by WB.
Figure 2. Antibody specificity using western blots. A. Full length
western blots with single lanes loaded with 25 mg of protein/lane
demonstrating the relevant bands (*) used for quantification in other
experiments. Antibodies against GAPDH, total MLC20, PMLC20 and
diphospho-MLC20 (PPMLC20) each identified one prominent band,
though faint ‘‘non-specific’’ bands appeared with the anti-GAPDH and
anti-PPMLC20 antibodies. B. Western blots performed as in panel A but
with the addition of phos-tag (30 mM) to the gel matrix to promote
mobility shifts in phosphorylated proteins. Probing for total MLC20
reveals 3 bands corresponding to unphosphorylated (0 P), mono-
phosphorylated (1 P), and diphosphorylated (2 P) MLC20. The anti-
PMLC20 antibody reacts with mono- and diphosphorylated MLC20 and
fails to recognize the unphosphorylated species. The anti-PPMLC20
antibody recognizes primarily diphosphorylated MLC20 and demon-
strates almost no cross-reactivity with the unphosphorylated or mono-
phosphorylated MLC20. Molecular weight markers (MW) are shown to
the left of each blot.
doi:10.1371/journal.pone.0009965.g002
Figure 3. Signal linearity with the in-cell western assay. A. 96-
well microplates were loaded with an increasing number of cells/well.
Signals from anti-GAPDH and anti-PMLC20 antibodies appear as green
fluorophores. Signals from cell dyes (cell number normalization) appear
as red fluorophores. B. Quantification of signals shown in panel A.
Normalized values are expressed as a fraction of the signal intensity of
the wells containing 15,000 cells for GAPDH (N), PMLC20 (m). The signal
from the cell dyes also is shown (&). The GAPDH and PMLC20 signals
appear to plateau at the higher cell densities so the line of best fit has
been calculated and illustrated by expressing the normalized values as a
fraction of the intensity of the wells containing 10,500 cells (inset) for
GAPDH (N), and PMLC20 (m).
doi:10.1371/journal.pone.0009965.g003
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and PMLC20 in the ICW, we visualized the signals using
immunofluorescence microscopy (Figure 4). Slides for microscopy
were prepared identically to ICW plates (see methods) to ensure
that the microscopic visualizations were directly comparable to
ICW measurements. The only difference in protocols was the use
of secondary antibodies conjugated to Alexa-Fluor 488 for primary
antibody detection for microscopy. Each slide was also stained
with rhodamine-phalloidin to demonstrate filamentous actin (F-
actin). In the absence of primary antibodies, there is no
appreciable signal (Figure 4A panels i and ii). Using the antibody
to GAPDH, there is diffuse cytosolic staining, in marked contrast
to the filamentous appearance of F-actin (Figure 4A panels iii and
iv). For total MLC20 (Figure 4A panels v and vi) the staining
pattern is similar to F-actin (and in contrast to GAPDH), in
keeping with the molecular co-localization of these elements of the
contractile apparatus. There is no appreciable signal after pre-
adsorption of the PMLC20 antibody with a specific blocking
peptide containing phospho-Ser
19 of MLC20 either in the resting
state (Figure 4B panels i and ii) or after stimulation with 100 nM
OT (panels iii and iv). Similarly, in our preliminary ICWs, the
signal from resting and stimulated cells was reduced to background
levels when the antibody toward PMLC20 was preadsorbed with
the same blocking peptide. In the absence of the blocking peptide,
there is only a faint signal in resting cells (Figure 4B panels v and
vi) but this signal is rapidly inducible (20-second stimulation) in
response to OT. The subcellular distribution for PMLC20 is
identical to that of total MLC20 and F-actin (panels Avi, Bvii).
Assay Precision for WB and ICW
To assess assay precision, we studied the intra-assay and inter-
assay variability of each technique for GAPDH and PMLC20.W e
also evaluated the variability of normalization of PMLC20 to a
‘‘housekeeping’’ protein such as GAPDH and compared this to
normalization using the cell dye markers in the ICW technique.
For WB, two SDS-PAGE mini-gels were loaded with 13 replicates
of 20 mg of protein/lane from the same lysate. The resultant blots
(Figure 5A) were prepared simultaneously from the same
electrophoresis and transfer tanks. By using secondary antibodies
with distinct fluorophores, both proteins were assessed on each
blot. The intra-assay variability in signal intensity across the lanes
for GAPDH and PMLC20 is presented in Figure 5B. The intra-
assay coefficients of variation (CV) for GAPDH and PMLC20 were
0.21 and 0.20 in blot 1, respectively, and 0.16 and for both
proteins in blot 2. Blot 1 particularly emphasizes that the pattern
of signal variation across the lanes was not similar for the two
proteins. Hence, when the ratio of one protein to the other was
Figure 4. Antibody specificity using the in-cell western assay. In
each pair of micrographs, the left panel illustrates filamentous actin (F-
actin) stained with rhodamine-phalloidin (red). The corresponding right
panels are immunofluorescence micrographs stained with antibodies
conjugated to Alexa-Fluor 488 (green). Nuclei are stained with DAPI
(blue) in all panels. Images are shown at 4006and 2006magnification
in panels A and B, respectively. White bars represent 25 and 50 microns,
respectively. A. Demonstration of GAPDH and total MLC20. Panels i and
ii. The actin fibers stain in a filamentous pattern typical of uterine
smooth muscle. There is no detectable signal with omission of the
primary antibodies. Panels iii and iv. The GAPDH staining shows a
diffuse cytosolic pattern in contrast to the fibrillar pattern of actin.
Panels v and vi. Total MLC has a similar staining pattern to actin. B.
Demonstration of PMLC20. Panels i–iv. There is no detectable
background fluorescence when the antibody has been preadsorbed
with blocking peptide (BP) containing phospho-Ser
19 of MLC20, either in
the resting state (panel ii) or with stimulation using 100 nM OT (20 sec
stimulus, panel iv). Only a small amount of PMLC20 is detectable in the
resting myocyte (panel vi) but this is markedly increased upon
stimulation with OT (100 nM, 20 sec: panel viii).
doi:10.1371/journal.pone.0009965.g004
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determine the intra-assay CV for the ICW technique, 30 wells in
each of two plates were prepared simultaneously and probed for
PMLC20 or GAPDH. The CV for signals obtained for PMLC20
(Plate 1), and GAPDH (Plate 2) were 0.10 and 0.07. The CV for
the cell dye estimate of cell content for plates 1 and 2 were 0.05
and 0.15, respectively. When the concentrations of PMLC20 or
GAPDH were normalized to the cell dyes, the CV varied from
0.08 to 0.16. In summary, the intra-assay CVs for measurement of
PMLC20 and GAPDH alone are comparable between ICW and
WB but the ICW technique may have a slight advantage regarding
the precision of the normalized data.
The inter-assay CVs were calculated from repeated measure-
ment of the same samples at different times using different blots for
WB or on several different plates for ICW. The inter-assay CV
with the ICW technique was 0.08 for PMLC20 and 0.15 for the
ratio of PMLC20 to the cell dyes. For the WB technique, the inter-
assay CV was 0.16 for PMLC20 and 0.25 for the ratio PMLC20 to
GAPDH.
Measurement of Myosin Light Chain Phosphorylation in
Response to a Physiological Stimulus
ICWs were used to measure the effects of cell density, time
course and concentration-responses for OT–induced PMLC20
formation. Visual inspection of myocyte cultures seeded at various
densities revealed that they were nearing confluence in the range
between 500–700 cells/mm
2 (not shown). Subsequent experi-
ments were aimed at determining the optimal cell density and time
course for OT-induced PMLC20 formation. Stimulation with
increasing concentrations and incubation times of OT for cell
densities of 500, 550, 600, and 650 cells/mm
2 demonstrated that
the largest amplitude concentration-dependent rise in PMLC20
inducible by OT is achieved at a cell density of 600 cells/mm
2
after treatment for 20 seconds (Figure 6). At a density of 650 cells/
Figure 5. Assessment of intra-assay variability in western blots
and ICW assays. A. WB membranes showing GAPDH and PMLC20
levels in 13 replicate samples in two western blots. B. In the panels on
the left are the individual band intensities from WBs in A expressed as a
proportion of the mean of the thirteen samples in each of the two blots.
The data from blot 1 are shown in blue and from blot 2 in red. The data
are provided for GAPDH and PMLC20 individually and for the ratio
GAPDH/PMLC20. In the panels on the right are the intensities of the
signals from wells distributed across ICW plates plotted as a proportion
of the mean values for each of two plates (plate one in blue and plate 2
in red). The data are provided individually for GAPDH, PMLC20, and in
the lowermost panel for the cell dyes used in data normalization. The
ratios of GAPDH and PMLC20 to the cell dyes are also shown in red and
blue, respectively.
doi:10.1371/journal.pone.0009965.g005
Figure 6. Cell density optimization for the in-cell western
assay. Uterine myocytes were seeded at densities of 500 (darkest
histogram in each grouping), 550, 600 and 650 (lightest histogram in
each grouping) cells/mm
2. Cells were treated with increasing concen-
trations of OT (10
210 to 10
27 M) for 20, 30, 45 or 60 seconds or 2 or 5
minutes (n=4 at each time point at each concentration of OT).
Concentrations of PMLC20 were measured using the ICW assay. PMLC20
levels rose rapidly (20 sec), decayed significantly by 1 min, and returned
to baseline levels by 5 min. The largest amplitude concentration-
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2 and at time points beyond 20 seconds for all densities tested,
the response to OT was diminished.
We next determined the time course of the concentration-
response relationships of OT stimulation of uterine myocytes (at
600 cells/mm
2) with respect to PMLC20 concentrations by WB
and ICW under identical conditions (Figure 7). Using the ICW
technique, a brisk response is measurable as early as 20 seconds
after stimulation, then decays significantly by 1 min and returns to
baseline levels by 5 min (Figure 7A). Qualitatively, the responses
obtained by WB were similar with increases in PMLC20 formation
acutely (,1 min) and decay of PMLC20 beyond 1 min. However,
there were differences between the techniques with respect to
quantitative data. In the first WB experiments, wet-ice cooled PBS
and a lysis buffer containing phosphatase and protease inhibitors
(see methods) was used to extract the protein. The maximal
response to OT was measured at 171626% of control values
(Figure 7B) compared to the 329637% using the ICW technique
(Figure 7A). Since the PBS/lysis buffer is a rather mild extraction
technique, we repeated the experiments using the more stringent
dry-ice-cooled TCA/Acetone/DTT extraction method. This
enhanced the maximal response to OT to 321620% (Figure 7C)
but the variability about the measurements appeared greater than
with the ICW technique. In summary, the ICW and WB
techniques yielded similar patterns of biological data with a
suggestion that the ICW might have superior precision.
Physiological Validation of Myosin Light Chain
Phosphorylation Measured by In-Cell Western Assays
To reinforce the physiological validity of the responses
measured by ICW, we performed experiments in the presence
or absence of pharmacologic inhibitors known to perturb the
biochemical pathways mediating phosphorylation of MLC20.
Uterine myocytes were seeded at 600 cells/mm
2 and stimulated
with OT (100 nM, 20 sec). Inhibition of MLC20 Kinase (MLCK)
(ML7, 50 mM), calmodulin (CaM) antagonism (W7, 50 mM),
inhibition of phosphatidyl-inositol-specific phospholipase C (PLC)
(edelfosine, 20 mM), and inhibition of plasma membrane calcium
(Ca
2+)-channels (nifedipine, 20 mM) significantly attenuated the
OT-induced rise in PMLC20, as assessed by two-way ANOVA
(p,0.0001, Figure 8). These results indicate that the phosphor-
ylation of MLC20 measured by ICW behaves as expected in
accordance with current knowledge of the biochemical pathways
mediating physiological PMLC20 responses in smooth muscle cells.
[13,14]
Discussion
Protein phosphorylation is the most commonly studied post-
translational modification due to its central role in regulating
cellular physiology. PP levels are dynamically regulated in
Figure 7. Comparison between WB and ICW for cell responses
to OT. For each of the figures, the top panel (i) presents the raw data
and the lower panel (ii) presents a graphical analysis of the normalized
and quantified data (n=2–4 for each histogram). For the ICW data,
PMLC20 concentrations were normalized using the cell dyes and with
the WB data, PMLC20 values were normalized to GAPDH. The
normalized data are expressed as a percentage of the vehicle (V)
controls. A. Data from the ICW assay. Background wells (B) had no
primary antibody or cell dyes. Cells were plated at a density of 600 cells/
mm
2 and treated with vehicle or increasing concentrations of OT (10
210
to 10
27 M). The time course varied from 20 sec (darkest histogram in
each grouping) through 30, 45 and 60 sec or 2, 5 or 10 minutes (lightest
histogram in each grouping). B. The treatment and time protocols were
similar to figure 7A. The protein was extracted under mild (cold PBS/
Lysis Buffer) conditions and the proteins measured using western blots
as indicated. C. Experimental protocol similar to B except that the
protein extraction was performed using the more stringent (TCA/
Acetone/DTT) conditions.
doi:10.1371/journal.pone.0009965.g007
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opposing activities of protein kinases and phosphatases. [15] These
enzymes encode external and internal signals through the
complement of PPs that are produced in the cell interior. Using
experimental manipulations rooted in knowledge of signaling
pathways, scientists can decipher the role of phosphorylated
intermediates in cellular responses provided they are quantifiable.
The increasing commercial availability of PP-specific antibodies
has enhanced the use of WB as a standard method for this
purpose.
The WB technique is a relatively labour-intensive and
technically demanding assay best suited for experimental ap-
proaches that require low-throughput measurements. Our data
demonstrate that the ICW technique provides signal linearity and
specificity at least equal to WB. The ICW technique also provides
biological response amplitudes similar to those attainable by the
very robust protein collection method using dry-ice cooled TCA/
Acetone/DTT, demonstrating that formalin fixation is a useful
and robust method for PP signal preservation. PMLC20 has
similarly been preserved and quantified reliably after cell fixation
in other reports. [16] The ICW and WB techniques are
qualitatively similar in terms of the concentration range of
measurable stimulation (100 pM to 100 nM) and the time course
for the rise and decay of the PMLC20. Both techniques were
capable of measuring PMLC20 formation as early as 20 seconds
post-stimulus. This rapid induction of PMLC20 agrees with other
OT-response data in the literature. [17,18] The diminished
responses measured by WB using the relatively mild cold PBS/
cold lysis buffer method could result from phospho-signal loss
during cell lysis and harvesting, since the time necessary to
complete these steps exceeds the optimal treatment length (20 sec)
for a maximal response in contrast to the nearly instantaneous
quenching achievable by TCA/Acetone/DTT and formalin
fixation. Because we have prepared both WBs and ICWs with
identical blocking and antibody incubation solutions, it is unlikely
that the diminished phospho-signal measured from cold PBS/cold
lysis buffer samples by WB is explained by residual phosphatase
activity present in the incubation buffers. [19]
The WB technique is considered by many to be a ‘‘semi-
quantitative’’ assay because of the relative lack of precision of the
measurements. Variability may arise from the protein extraction
method employed or from application of the protein to the gel.
Perhaps most problematic is the transfer of the separated proteins
to the blotting membrane. Uneven distribution of proteins across
blotting membranes may occur since protein movement out of the
polyacrylamide gel matrix occurs at unequal rates and to different
extents as influenced by protein MW and solubility in the transfer
buffer. [3,4,20,21,22] In particular, transfer conditions optimized
for smaller proteins may not be efficient for larger proteins, and
vice-versa. [3,23] In addition, the choice of membrane, blocking
and antibody solutions, and wash buffers may influence the
amounts of protein retained on the membranes before antibody
probing. [24,25] These factors introduce considerable inter-assay
variability, limiting the precision of the technique and ultimately
complicate protein quantification via WB.
The potentially improved precision of ICW compared to WBs
might be attributable to minimizing sample handling through
elimination of protein extraction, electrophoresis, and protein
transfer steps. Use of a calibrated digital multichannel pipette
further reduces assay variability by allowing rapid treatment and
quenching of many samples nearly simultaneously. In addition, the
ability to take duplicate or higher number replicate measurements
may further enhance precision. Though replicate measurements
are feasible in the setting of WB, this is an uncommon, but perhaps
advisable, practice. [26] Further, our data demonstrate that WBs
may have significant lane-to-lane variability in protein transfer
evidenced by inconsistencies in protein signals within and between
membranes. This variability is inconsistent between two protein
signals (PMLC20, GAPDH) and this has the potential to magnify
the variability when the measurements of one protein are
normalized to that of another protein. By comparison, with the
ICW technique, the normalization of a protein to the cell content
of the well using a combination of cell dyes appeared to give more
precise normalization data (Figure 7).
In our evaluation of acute phosphorylation responses, data
normalization was straightforward since protein levels were
constant. However, where experiments concern longer treatment
courses, it may be prudent to avoid data normalization to that of a
reference protein and instead opt to use the cell dyes to avoid
inaccurate interpretation of results due to changing reference
protein levels. The potential for wavering levels of reference
proteins has prompted others to suggest alternatives for data
normalization in WBs. [26]
In the absence of purified antigen, it is impossible to obtain valid
assessments of the sensitivity of assays such as WB or ICW.
However, our data suggest that the ICW technique yields a precise
measure of antigens down to 0.3 mg protein/well. As noted in
Figure 3B, there is a high correlation with the linear plot down to
0.3 mg protein/well for all three proteins. This is in contrast to WB
where the lower limit of signal discrimination for band intensities
for GAPDH was 1.6 mg protein/lane. As GAPDH was the most
intense signal measurable in our WB experiments, it is unlikely
that PMLC20 or total MLC20 would be quantifiable below this
level.
Figure 8. Assessment using the ICW technique of pharmaco-
logical manipulation of PMLC20. Uterine myocytes were seeded in
microplate wells at 600 cells/mm
2 and treated with OT (from 10
214 to
10
26 M) for 20 sec in the presence or absence of 15-minute pre-
incubation with specific pharmacological agents (n=7 separate
cultures). The normalized data are expressed as a percentage of the
vehicle controls. As expected, the cells demonstrated a brisk response
to OT that was diminished in the presence of an inhibitor of MLCK (ML-
7, 50 mM), CaM (W7, 50 mM), phosphatidyl inositol-PLC (Edelfosine,
20 mM), and L-type Ca
2+ channels (Nifedipine, 20 mM). Relative PMLC20
levels (normalized to cell content) are expressed as a percentage of
vehicle control. All of the pharmacological agents significantly
(p,0.0001) attenuated the concentration-dependent PMLC20 increase
induced by OT as determined by two-factor ANOVA.
doi:10.1371/journal.pone.0009965.g008
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importance in the ICW technique. It has been suggested that the
antibodies proposed for evaluation of protein antigens in fixed cells
should be tested for signal intensity and specificity by WB. [27]
Reliance on WB for evaluation of antibody specificity (or rather,
the level of non-specificity) for what is essentially a microscopy
application in ICW, presupposes that the proteome is represented
identically in both techniques. However, antigen preparation is
achieved using different methods for WB (reduction and
linearization with DTT or 2-mercaptoethanol, and SDS) and
microscopy (organic denaturation and fixation by cross-linkages).
Therefore, the complement of cellular antigens is presented to the
antibody in a different configuration. Hence, validation of
antibody specificity for ICW using WB may prove most useful
where the antibody recognizes a continuous epitope that is fully
unmasked during fixation. Whether the antibody will interact with
epitopes in partially denatured proteins cannot be addressed by
this approach. Logically then, WB data are less appropriate for
validation of antibodies raised against discontinuous epitopes
encompassing amino acid residues in close proximity on the
surface of a protein but separated in space in the linear amino acid
sequence. This may be a more significant consideration for
antibodies raised against short peptides (both mono- and
polyclonal), in contrast to those (polyclonals) raised against various
parts of the immunizing protein. [23,28] One potentially less
significant consideration here is that the proteome is unlikely to be
represented in its entirety on a WB membrane since the gel
polyacrylamide content (gel percentage) is selected so as to
optimize resolution of the POI from other cellular proteins. This
may result in exclusion of low MW proteins on the resultant WB if
a low percentage gel is used, and may under-represent the
complement of large MW proteins if a high gel percentage is
selected due to their restricted mobility out of the gel during
protein transfer. Thus, if one insists on WB validation of ICW
antibodies, it may be useful to employ gradient gels to resolve a
large MW range for this purpose. In any case, it is important to
demonstrate that the antibody will detect the POI using
microscopic techniques with appropriate negative controls to rule
out non-specific signals. This is particularly crucial since ICWs
lack the ability to separate protein signals in space as is done in
WBs via SDS-PAGE.
The biggest advantages of the ICW assay compared to WB are
the diminished preparation time and resource utilization as well as
the potential for development of high-throughput assays with the
capability to scan multiple microplates simultaneously. We also
believe that the relatively small amount of cellular material in each
well allows rapid quenching of treatments and preservation of the
cell-interior by simple addition of fixing solution. This more
uniform and exact termination of experimental treatments likely
provides more precise information regarding dynamic reactions
that occur in rapid time courses, exemplified by many phosphor-
ylation reactions.
A principal prerequisite for performing ICWs is the availability of
a culture method allowing for an even distribution of cells across the
well surface. Cell cultures used for ICW can be adherent or non-
adherent. However, if they are adherent, the cells must grow as a
monolayer in culture, and, if non-adherent, must be prepared so
they lie in a monolayer at the time of scanning. This will ensure a
uniform signal from the well surface. In our studies, which used
freshly seeded uterine myocytes, there was an optimal density of
cells for a response to a physiological stimulus. The plateauing of
PMLC20 and GAPDH signals at higher cell densities inour linearity
assessment was unlikelyto beduetoexceeding the capabilitiesofthe
IR scanner, but rather to cell overcrowding, for two reasons. First,
therewerenosaturatedpixels inthe wellsignals.Second,inthetime
course assessment we detected higher signal intensities for PMLC20
at 600 cells/mm
2 in stimulated myocytes than those obtained by
simply plating a higher density of cells. It is likely that the optimal
density for a biological response is dependent on the cell type used,
as well as other conditions, and this parameter should be assessed
whenever a new cell type is studied.
Our data also demonstrate the validity of the ICW technique to
monitor physiological events in a dynamic system. Phosphoryla-
tion of MLC20 at Ser
19 results from influx of Ca
2+ ions into the
myocyte cytosol whether derived from the extracellular space
through plasma membrane channels, or from intracellular stores
whose release is triggered by the generation of inositol-trispho-
sphate by PLC. This Ca
2+ influx results in activation of MLCK by
the intermediary Ca
2+ binding protein, CaM. [13,14] We have
demonstrated that pharmacological manipulation of Ca
2+ flux,
CaM activity or MLCK itself has the predicted effects on
concentrations of PMLC20.
Clearly, there are significant limitations to the usefulness of the
ICW technique. Its application is restricted to the study of proteins
in cell cultures for which a specific antibody is available. It is not
suitable for study of PPs or other proteins from whole tissues or in
experimental situations where freshly isolated tissues are required
for simultaneous measurement of physiological and biochemical
endpoints. ICWs are also restricted to the study of proteins present
in high enough levels to be detectable from the cellular material in
a single well, as it is not possible to concentrate low-abundance
proteins. In contrast, WBs can be preceded by a protein-
concentrating or protein-purifying technique such as immunopre-
cipitation. Another disadvantage of ICWs is that they do not allow
determination of the stoichiometry of phosphorylation, such as can
be obtained using urea/glycerol PAGE [29] or via phos-tag [10]
SDS-PAGE. Further, unless one has access to an infrared
microscope, ICWs do not permit routine identification of the
proteins yielding the measured signal, which is verified in each WB
membrane using the MW marker. Lastly, whereas WBs are
routinely used to analyze samples that have been frozen in storage,
ICWs are unlikely to be useful in the same way since ice crystals
formed during freezing may damage the integrity of the cellular
structures necessary to obtain reliable data by this method.
Therefore, in our experience, ICWs should be used to analyze
microplates that have been stored only briefly (a few days) at 4uC.
We have not formally addressed the length of time that protein
phosphorylation is preserved in ICWs, and for this reason we
proceeded with the preparation of microplates immediately after
cell fixation. Our general observations are that some phospho-
antigens are stable over several days (perhaps weeks) after fixation
and storage at 4uC in PBS, but others decay more rapidly. Thus
the window of time for plate development must be determined
empirically for each PP.
In conclusion, we have provided validation of the use of the ICW
technique to assess rapid phosphorylation events in uterine
myocytes. It is likely that this technique is equally applicable to
many other cell types to assess many other physiological reactions.
We have demonstrated that there may be advantages of the ICW to
conventional WB techniques with respect to sensitivity and
precision and, depending on the proper validation of the antibody,
thetwotechniques areof similar specificity.The majoradvantage of
the ICW assay over WB is the relative ease of preparation of the
samples and the potentialforhigh-throughputdataproduction.The
increased relative cost of ICWs dueto the need forlower dilutions of
some antibodies is offset by the much higher throughput capacity in
addition to other savings in reagents by elimination of several
preparative steps from the WB protocol. Our data demonstrate that
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by NIR fluorescent WBs. Considering the technical aspects of the
two procedures, we conclude that the benefits of ICWs are
generalizable irrespective of the protein target of interest.
Materials and Methods
Ethics Statement
The protocol to obtain biopsies from the lower segment of the
uterus at the time of cesarean section was reviewed and approved
by the Human Ethics Review Board of the University of Alberta
and the Ethics Review Board of Capital Health, the provider of
health services in the region. A research nurse at the Royal
Alexandra Hospital in Edmonton obtained informed and written
consent from each patient.
Primary Myometrial Cell Cultures
Myometrial biopsies wereobtained fromthelowersegment ofthe
uterus from non-labouring patients at term (37–40 weeks) gestation
duringelective caesarean section. Biopsies were cut into small pieces
with ethanol-sterilized tools in a sterile cell culture hood, then
incubated in filter sterilized (0.22 mm) Hanks Balanced salt solution
(HBSS, Gibco, (Invitrogen, Carlsbad, CA)) containing 1% antimy-
cotic/antibiotic (Gibco; 10,000 U/mL of penicillin, 10,000 mg/mL
of streptomycin, 25 mg/mL of amphotericin B), 2 mg/mL collage-
nase (Sigma-Aldrich, St. Louis, MO), and 200 ng/mL DNase I
(Roche, Laval, QC) in a 50 mL conical tube (Corning) in a total
volume of 10 mL of the prepared HBSS. These tubes were
incubated for 1 hr at 37uC with shaking. After 1 h, the debris was
allowed to settle and the supernatant (containing fibroblasts) was
discarded. The remaining tissue was incubated in another 10 mL of
prepared HBSS at 37uC while shaking, for 4 hrs to overnight (O/
N). The dispersed cell mixture was filtered through a 100 mm cell
strainer, centrifuged at 20006g for 5 min, and washed twice with
sterile phosphate buffered saline (PBS). Isolated uterine myocytes
were grown in Dulbecco’s modified Eagle’s medium (DMEM,
Gibco) supplemented with 10% fetal bovine serum (FBS, Gibco)
and 1% antimycotic/antibiotic (Gibco) at 37uC in humidified 5%
CO2/95% air. Cell cultures were grown to 80–100% confluence in
a single well of a 6-well plate post-isolation from tissue biopsies, then
in T25 and T75 flasks (Ultident, St. Laurent, QC). Incubation at
37uC with trypsin (0.05%, Gibco) was used to free cells from the
substrate. An excess of culturing medium was used to quench the
trypsinization reaction. Cells were monodispersed by vigorous
pipetting, counted using a hemocytometer and then plated at the
desired cell density onto sterile black-walled 96 well (Greiner Bio-
One, Monroe, NC) microplates for ICW, in sterile 6-well plates
(Corning, Lowell, MA) for WB, or on 8-chamber slides (VWR Int.,
USA) for fluorescence microscopy experiments. Prior to experi-
ments, the cells were washed once with pre-warmed DMEM
containing no additives, and then placed into the incubator in
DMEM without additives for 2–4 hrs. All stimulants, pharmaco-
logic agents, and drug diluents (DMSO) were diluted in DMEM
without additives to the final concentration prior to experiments.
Oxytocin (OT), ML-7 (MLC20 Kinase inhibitor), W7 (calmodulin
antagonist), edelfosine (phospholipase C inhibitor), and nifedipine
(calcium channel blocker) were all acquired from Calbiochem.
Total Protein Extraction
For WB, total cellular protein was extracted by two methods.
Method 1: cells were washed after treatment with ice-cold PBS
followed by addition of ice-cold lysis buffer containing 50 mM Tris-
HCl pH 8.0, 137 mM NaCl, 5 mM EDTA, 0.1% Triton X-100,
1 mM PMSF, 1X protease inhibitor cocktail (Sigma-Aldrich, Final
concentrations: 1.04 mM ASBSF, 0.8 mM Aprotinin, 21 mM
Leupeptin, 36 mM Bestatin, 15 mM Pepstatin A, 14 mM E-64),
and 1X phosphatase inhibitor cocktail (PhoSTOP, Roche) for
detection of PPs. Cells were freed from the substrate using a cell
scraperand collectedintowet-ice-cooled microfugetubes,thensnap
frozen in liquid nitrogen and stored at 280uC for later use. Protein
concentrations were determined by combining 1 part sample to 99
parts Precision Red
TM advanced protein measurement reagent
(ADV02, Cytoskeleton, Denver, CO, USA) according to the
manufacturer’s instructions. Method 2: after treatment, cells were
lysed in an acetone solution containing 10% trichloroacetate (TCA)
10 mM dithiothreitol (DTT), and protease inhibitors as indicated
above. This solution was pre-cooled in a dry-ice methanol bath
before addition to the culture plate. Cells were immediately scraped
from the substrate as above, and then collected into wet-ice-cooled
microfuge tubes. These tubes were centrifuged at 18,0006g for
30 min at 4uC, the supernatant was removed, and the pellet was
resuspended by vortexing in acetone containing 10 mM DTT, and
allowed to sit O/N. The next day, tubes were centrifuged at
18,0006g for 15 min at 4uC. The washing solution was removed
and the pellets were allowed to air-dry for 20–30 min. The dried
pellets were resuspended in 60 mL of 1X SDS-PAGE loading buffer
(see below) and incubated at 65uC for 10 min before storage or
loading 17.5 mL from each onto SDS-PAGE minigels.
SDS-PAGE and Protein Transfer
Total protein was prepared for electrophoresis by adding 5X
loading buffer (Final concentrations: 10% glycerol, 3% SDS w/v,
85 mM Tris HCl pH 6.8, 85 mM dithiothreitol, 0.1% bromophe-
nol blue) and boiling for 10 minutes. Approximately 25 mg/lane of
protein was loaded onto 15% or 18% Tris-Glycine-SDS minigels,
or alternatively, onto 12% gels with or without 30 mM phos-tag [10]
reagent (NARD Institute, Ltd., www.phos-tag.com) combined with
60 mMMnCl2 todemonstrateshiftsinmobilityforPPs.SDS-PAGE
was carried out in 1X SDS running buffer (10X Tris-Glycine-SDS
buffer, BioRad, Hercules, CA, USA) using a constant current of
15 mA for the stacking (4.2% acrylamide, pH 6.8) gel and then a
constant 25–30 mA for the separating (15% or 18% acrylamide,
pH 8.8) gel in a Mini-PROTEAN 3 electrophoresis apparatus
(BioRad), according to the Laemmli method. [30] Precision Plus
Protein all blue standard (2.5 mL/lane, BioRad) was loaded on each
gelforvisualizationinthe 700-channeloftheOdysseyH imager.The
gel was transferred to nitrocellulose (Li-COR, Biosciences, Lincoln,
NE, USA) at 4uC in a Mini-Trans-Blot cell (BioRad) apparatus
using a buffer containing 20% MeOH and 1X Tris-Glycine (10X
Tris-Glycine, Li-COR) for 1.5 hrs at 100 V. Gels containing phos-
tag and MnCl2 were incubated at room temperature (R/T) for 15–
20 min in transfer buffer of the same composition supplemented
with 2 mM EDTA to chelate and remove Mn
2+ ions, then allowed
to equilibrate in transfer bufferwithout EDTA for an additional 15–
20 min prior to transfer.
Western Immunoblotting
After transfer, membranes were rinsed briefly in PBS. Nitrocel-
lulosemembraneswere placedinto OdysseyH blockingbuffer(OBB,
Li-COR) diluted 1:1 with PBS immediately and blocked for 1 hr at
R/T. Primary antibodies were diluted in OBB combined 1:1 with
PBS, containing 0.1% Tween-20, and incubated O/N at 4uC. The
final antibody concentrations used were 1:1000 for GAPDH (mouse
MAb, Santa Cruz), 1:500 for MLC20 (Rabbit PAb, Cell Signaling),
1:200 for PMLC20 (rabbit PAb, Cell Signaling), and 1:200 for
PPMLC20 (diphospho Thr
18 Ser
19, rabbit PAb, Santa Cruz). After
primary antibody incubations, membranes were washed 3X
(10 min each) with PBS containing 0.1% Tween-20 (PBS-T) at
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IRDye 800CW (Li-COR) or Alexa Fluor 680 (Molecular Probes,
Invitrogen) were diluted to 1:20,000 in OBB combined 1:1 with
PBS, containing 0.1% Tween-20 and 0.01% SDS. Membranes
were incubated with secondary antibody solutions for 1.5 hrs at R/
T and in the dark on a bench top shaker. After secondary antibody
incubations, the membranes were washed 3X (10 min each) with
PBS-T at R/Ton a benchtop shaker in the dark,then brieflyrinsed
in PBS before scanning. Membranes were scanned and analyzed
using an OdysseyH IR scanner using OdysseyH imaging software
3.0. Scan settings were medium or high image quality, 169 mm
resolution, intensity 3.0–5.0 for both channels with no offset.
Antibody signals were analyzed as integrated intensities of regions
defined around the bands of interest in either channel.
In-Cell Westerns
Cellswere plated in sterileblack-walled 96 (half-area) (Greiner Bio-
One, Monroe, NC) plates at the desired density then placed at R/T
for 30–60 minutes before transfer to the incubator to reduce excessive
settling at the well edges. [31] The plates were incubated O/N at
37uC as indicated above. Prior to treatment, all wells were washed
with DMEM, and incubated in DMEM for 2–4 hours before
beginning the experiments. Cell treatments were dispensed with a
calibrated digital multichannel pipette with a repeater function to
ensure accuracy in treatment timing. After treatment, cells were fixed
immediately by adding concentrated formalin to a finalconcentration
of 3.7% formaldehyde and incubating at R/T for 10 minutes. After
fixation, the plates were washed with PBS then permeabilized by
washing 3X (10 min each) on a bench top shaker with PBS
containing 0.1% Triton-X-100, and then rinsed once with PBS. Cells
were blocked using 20 mL/well OBB for 1 hr at R/T. Primary
antibodies were prepared as for WB and the plates were incubated
O/N at 4uCu s i n g2 0mL/well. The final antibody concentrations
used were 1:500 for GAPDH (mouse MAb, Santa Cruz) and 1:200
for PMLC20 (Rabbit PAb, Cell Signaling). After primary antibody
incubations, plates were washed 3X (10 min each) with 100 mL/well
PBS-T at R/T on a bench top shaker. Secondary antibodies were
prepared as for WB with a few modifications: IRDye 800CW
conjugates of Goat-anti-rabbit-IgG (Li-COR), goat-anti-mouse-IgG
(Li-COR) were used at 1:1000 dilution for detection of antibody
targets in the 800-channel (green pseudocolor). 800-channel antibody
signals were normalized to the 700-channel (red pseudocolor) signals
derived from Alexa-Fluor 680 conjugated goat-anti-mouse-IgG
secondary at 1:1000 (Molecular Probes, Invitrogen), or DRAQ5
(Biostatus Ltd., Leicestershire, UK) combined with Sapphire700 (Li-
COR) at 1:10,000 and 1:1000 respectively. Plates were incubated
with 20 mL/well secondary antibody solutions for 90 min at R/T in
the dark. Background control wells were prepared by omitting
primary antibodies, DRAQ5 and Sapphire700 (i.e. secondary only).
After secondary antibody incubations, plates were washed 3X
(10 min each) with PBS-T at R/T on a bench top shaker in the
dark, and then filled with 50 mL/well PBS to reduce surface
disturbances when scanning. Plates were scanned and analyzed using
an OdysseyH IR scanner using OdysseyH imaging software 3.0. Scan
settings were medium or high image quality, 169 mmr e s o l u t i o n ,
intensity 5.0 for the 700-channel, and 7.0 for the 800-channel with an
offset of 4.0 mm. For signal quantification, antibody signals were
analyzed as the average 800-channel integrated intensities from
duplicate wells normalized to the 700-channel signal integrated
intensity to correct for well-to-well variations in cell number. Results
are expressed as percent relative responses (means 6 standard errors
of the mean) compared to vehicle-treated controls.
Microscopy
8-chamber sterile culture slides (BD Falcon) were seeded, cultured,
treated, fixed, and prepared for fluorescence or brightfield micros-
copy exactly as culture plates for ICWs,with the exception of utilizing
a lower dilution of primary antibodies (1:50 MLC20 (Rabbit PAb,
Cell Signaling), 1:50 PMLC20 (Rabbit PAb, Cell Signaling), 1:200
GAPDH) and DyLight 488-conjugated goat-anti-rabbit-IgG (Cell
Signaling) and goat-anti-mouse-IgG (Cell Signaling) antibodies at a
dilution of 1:100. After secondary antibody application, cells were
rinsed 3X in PBS-T and then incubated with 50 nM rhodamine-
phalloidin (Cytoskeleton, Denver, CO, USA) for 10 min at R/T to
reveal F-actin fiber distribution. Slides were rinsed 3X in PBS then
mounted inVECTASHIELD (Vector Laboratories,Burlington, ON,
Canada) mounting medium containing DAPI to detect nuclei. Slides
were allowed to rest for 60 min in the dark and stored at 4uCi f
necessary before visualizing under an Olympus IX81 fluorescent
microscope (Carson Scientific Imaging Group; Ontario, Canada)
using Slidebook 2D, 3D Timelapse Imaging Software (Intelligent
Imaging Innovations Inc.; CO, U.S.A.).
Statistical Analysis
The results were expressed using means (6S.E.M.). Statistical
analysis was performed using One-way ANOVA to compare the
means of 3 or more groups at a time in OT-induced MLC20
phosphorylation time course studies. Two-factor ANOVA was
used to determine if pharmacologic inhibitors had an effect on the
OT-induced MLC20 phosphorylation. A P-value of 0.05 was used
to establish statistical significance.
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